Table 2.
Comparison between CPA and control group.
| Variable | CPA group | Control group | Significance (P-valuea) |
|---|---|---|---|
| Total number of patients | 48 | 323 | |
| Age (years) | 4.8 ± 4.5 | 6.7 ± 4.8 | .011* |
| Male | 56.3% | 54.8% | .878 |
| Pre-existing conditions | 100% | 91% | .022* |
| Prematurity (n; %) | 13; 27.1 | 31; 9.6 | .001* |
| Gestational age (n; mean ± SD) | 12; 33.69 ± 2.44 | 27; 32.08 ± 2,96 | .242 |
| Neurology (n; %) | 29; 59.2 | 23; 7.1 | <.001* |
| Gastroenterology (n; %) | 19; 39.6 | 47; 14.6 | <.001* |
| Syndrome | 20 | 14; | <.001* |
| Genetically confirmed | 12; | 11; | <.001* |
| Not confirmed | 8; | 3; | <.001* |
| Cardiology | 21; | 24; | <.001* |
| Orthopedics | 10; | 12; | <.001* |
| Pulmonology | 44; | 278; | .285 |
| Protracted bacterial bronchitis | 5; | 49; | .384 |
| Oncology | 3; | 23; | .826 |
| Psychology | 3; | 7; | .103 |
| Rheumatology/immunology | 4; | 27; | .995 |
| Endocrinology | 4; | 14; | .229 |
| Nephrology | 3; | 9; | .206 |
| Urology/gynecology | 2; | 3; | .074 |
Differences between both groups in regard to age, gender and the presence of pre-existing conditions.
a
P-value was computed by Chi-Square test for independence for categorial data and by Student’s t-test or Welch’s test for continuous data.
*
Significant P-values.